OTC · AOXG
Aoxing Pharmaceutical Company, Inc.
$0.00$0.00 (0.0%)
Aoxing Pharmaceutical Company, Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
Loading market information…
OTC · GSAC · USD
Stock price, earnings
Quote as of Oct 29, 2026, 01:34 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
GelStat Corporation’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow GelStat Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Aoxing Pharmaceutical Company, Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
$0.00$0.00 (0.0%)
Real Brands, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
SFLMaven Corp.: Financial Services · Shell Companies.
$0.00$0.00 (0.0%)
ViaDerma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.75% below the high.
$0.00$0.00 (0.0%)
Link Reservations Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00-$0.00 (-50.0%)
Grapefruit USA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.67% below the high.
$0.00$0.00 (0.0%)
Pazoo, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
4Front Ventures Corp.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
